The Patent Finder

Strox Biopharmaceuticals, LLC

Also on record
Records under this name other than patents Strox Biopharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Strox Biopharmaceuticals, LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,322,788Anti-bacterial antibodies and methods of use
Term ended
Term ended Aug 20, 2019 · USPTO record
Term endedTerm ended Aug 20, 2019USPTO record
US 7,795,402Anti-Staphylococcus aureus antibodies
Term ended
Ended no later than Aug 20, 2019 · USPTO record
Term endedEnded no later than Aug 20, 2019USPTO record
US 8,142,780Anti-bacterial antibodies
Term ended
Ended no later than Aug 20, 2019 · USPTO record
Term endedEnded no later than Aug 20, 2019USPTO record
US 7,569,677Antibiotic-conjugated antibodies
Lapsed on the fee record
Ended Aug 4, 2017 · USPTO record
Lapsed on the fee recordEnded Aug 4, 2017USPTO record
US 6,475,788Anti-bacterial antibodies and methods of use
Lapsed on the fee record
Ended Nov 5, 2014 · USPTO record
Lapsed on the fee recordEnded Nov 5, 2014USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited